TrialDiabetes care2020

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).

Alexander S Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.